Omega Therapeutics Inc. Common Stock is a pioneering biotechnology company focused on developing RNA-based therapeutics to treat a range of diseases. Their innovative approach utilizes the power of regulatory RNA to precisely tune gene expression, promising transformative outcomes in the field of precision medicine.
